1. Home
  2. TECX vs GSIT Comparison

TECX vs GSIT Comparison

Compare TECX & GSIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$33.31

Market Cap

393.0M

Sector

N/A

ML Signal

HOLD

Logo GSI Technology

GSIT

GSI Technology

HOLD

Current Price

$8.51

Market Cap

314.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
GSIT
Founded
2019
1995
Country
United States
United States
Employees
51
N/A
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
393.0M
314.5M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
TECX
GSIT
Price
$33.31
$8.51
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$80.40
N/A
AVG Volume (30 Days)
380.4K
623.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
47.50
EPS
N/A
N/A
Revenue
N/A
$20,518,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.70
$1.62
52 Week High
$35.99
$18.14

Technical Indicators

Market Signals
Indicator
TECX
GSIT
Relative Strength Index (RSI) 67.84 59.69
Support Level $16.83 $3.08
Resistance Level $35.99 $8.99
Average True Range (ATR) 2.81 0.69
MACD 0.91 0.08
Stochastic Oscillator 80.72 83.82

Price Performance

Historical Comparison
TECX
GSIT

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About GSIT GSI Technology

GSI Technology Inc is a provider of semiconductor memory solutions. The company develops and markets high-performance memory products, including Very Fast static random access memory, or SRAM, that are incorporated in high-performance networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations, and network access equipment. It sells these products to original equipment manufacturers and customers including Nokia. In addition, it serves the ongoing needs of the military, aerospace, industrial, test and measurement equipment, and automotive and medical markets for high-performance SRAMs. It operates geographically in China, Singapore, the Netherlands, Germany, Rest of the world, and the United States.

Share on Social Networks: